Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Open Label Randomised Multicentre Study Evaluating the Efficacy & Safety of Rituximab Given Pre-Transplant to Sensitised Renal Allograft Recipients in Addition to a "Standard" Desensitisation Regimen Consisting of PE/IVIG & MMF

NCT00371904 is registered in ClinicalTrials.gov with Hunter and New England Health as lead sponsor.

NCT NCT00371904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00371904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Open Label Randomised Multicentre Study Evaluating the Efficacy & Safety of Rituximab Given Pre-Transplant to Sensitised Renal Allograft Recipients in Addition to a "Standard" Desensitisation Regimen Consisting of PE/IVIG & MMF
Lead sponsor
Hunter and New England Health
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2006
Completion date
January 31, 2009
Enrollment
192 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation